Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study

Lukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen · 2026

Read Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study by Lukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13476277.txt.

Description

Lukas Schaffarczyk and co-authors test rapid antibiotic susceptibility testing in bloodstream infections in a 2026 study. Knowing quickly which antibiotics work lets doctors stop broad first-guess therapy sooner. The hospital adopted the EUCAST rapid method, and the team compared four-month periods before and after adoption at one German center.

The study covered 126 patients with single-organism bloodstream infections from four bacterial species. After adoption, first-guess therapy lasted about forty hours instead of seventy-three. Rapid results arrived in about sixteen hours, far faster than the standard system, and agreement between methods was near perfect for most drugs. Some borderline results needed stand-in interpretation rules. The authors judge the rapid method practical for routine care.

Catalog record

CREATORLukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13476277

Browse the full library · About the Tower of Babel